Ansell reported $175.3M in EBITDA for its first fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Ansell ANN:AU $ 175.3M 15.3M
Australian Pharma API:AU $ 73.76M 14.77M
Cochlear COH:AU $ 230.2M 171.4M
CSL CSL:AU $ 2.67B 1.27B
Fisher Paykel Healthcare FPH:NZ 341.2M 90.7M
GUD GUD:AU $ 57.11M 15.92M
Healius Ltd HLS:AU $ 85.5M 133.2M
Japara Healthcare JHC:AU 31.6M 34.46M
Mayne Pharma MYX:AU $ 39.51M 15.08M
Nanosonics Ltd NAN:AU $ 3.3M 5.32M
Next Science Ltd NXS:AU -5218190 1.35M
Polynovo Ltd PNV:AU -1446020 244.16K
Ramsay Health Care RHC:AU $ 977.6M 163.37M
Regis Healthcare REG:AU 66.45M 21.88M
Sigma Healthcare Ltd SIG:AU 35.35M 12.3M
Somnomed Ltd SOM:AU 2.57M 3.22M
Sonic Healthcare SHL:AU $ 1.31B 583.63M